▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Cintas Q3 23 Earnings Conference Call At 10:00 AM ET

By RTTNews Staff Writer ✉ | Published: 3/29/2023 6:00 AM ET

Cintas Corporation (CTAS) will host a conference call at 10:00 AM ET on March 29, 2022, to discuss Q3 23 earnings results.

To access the live webcast, log on to https://www.cintas.com/investors/earnings-webcast/event-details/

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In March 2023

Latest Updates on COVID-19

FDA Approves Pfizer's COVID-19 Pill Paxlovid

US Revokes Covid Vaccination Requirement For International Air Travel

SD Biosensor Recalls Certain COVID-19 At-Home Tests Distributed By Roche

Read More

COVID-19: Drugs in Development

RELATED NEWS

Cintas Boosts FY23 Outlook - Update

Cintas Corporation Q3 Profit Increases, beats estimates

Cintas Q3 23 Earnings Conference Call At 10:00 AM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

Macy's, Dollar General Q1 Profits Decline

FDA Warns Retailers Against Illegal Sales Of Disposable E-cigarettes

Tillamook Recalls Certain Waffle Cone Swirl Ice Cream Packaged In Chocolate Peanut Butter Carton

Mattel Unveils New Barbie The Movie Collection

Rudolph's OnYums Onion Flavored Rings Sold At Dollar Tree Recalled

Krispy Kreme, Dunkin' To Offer Free Donuts On National Doughnut Day

Cricket Creek Farm Recalls Sophelise And Tobasi Cheeses

Carvana Up 12%; Gets 'notable S&P Global Ratings Upgrades"

Pfizer Says Pivotal Phase 3 BASIS Clinical Trial Of Marstacimab Met Primary Endpoints

U-Haul Holding Shares Down On Lower Earnings In Q4

Seagen To Be Acquired By Pfizer For $43 Bln

Magnachip To Spin-off Display And Power Businesses Into Separate Entities

AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study

ACI Worldwide Appoints Thomas Warsop As New CEO

Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis

Trevena Achieves Listing Compliance On Nasdaq

Alterity Therapeutics Granted Initial Approval For Phase 2 Clinical Trial Of ATH434

Franklin Templeton To Buy Putnam Investments For $925 Mln

Mortgage Rates Jump Up

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis

Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

Dollar General Q1 Results Miss Estimates, Cuts FY23 View; Stock Down In Premarket

Balfour Beatty's JV Gammon Bags HK$3.7 Bln Contract In Hong Kong

JBT To Sell Its AeroTech Business To Oshkosh - Quick Facts

Advance Auto Parts Announces Retreat In Q1 Bottom Line

AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study

Chewy Q1 Results Beat Estimate; Shares Jump 11% After Hours

Dollar General Down In Pre-market On Q1 Results, Outlook

Macy's, Dollar General Q1 Profits Decline

TotalEnergies Renews OML130 Deep Offshore License In Nigeria